15 results
10-Q
2024 Q1
IMCR
Immunocore Holdings plc
8 May 24
Quarterly report
7:00am
approvals, manufacture drug product and drug supply, maintain and expand our intellectual property portfolio, as well as hire additional personnel, pay
10-K
2023 FY
EX-10.13
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
, Company shall, at its expense, hire a “Big 4” accounting firm to prepare Executive’s Home-Jurisdictions tax returns, prepare all other applicable
10-K
2023 FY
EX-10.12
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
are due pursuant to this Section for any tax year, Company shall, at its expense, hire a “Big 4” accounting firm to prepare Executive’s Home
10-K
2023 FY
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
intellectual property portfolio;
acquire or in-license other product candidates, intellectual property and technologies;
hire additional clinical … or will hire, requiring us to train new sales representatives. If we are unable to effectively train our sales force and equip them with effective
20-F
uope haae
25 Mar 21
Annual report (foreign)
7:01am
424B4
lkiv7hepj8
8 Feb 21
Prospectus supplement with pricing info
8:36am
F-1/A
nlq0ga55uauxb 4qs
3 Feb 21
Registration statement (foreign) (amended)
5:22pm
F-1/A
EX-10.18
2ifrqs3a
1 Feb 21
Registration statement (foreign) (amended)
6:21am
F-1/A
4rts85cb
1 Feb 21
Registration statement (foreign) (amended)
6:21am
F-1
lfg d8hopshl
15 Jan 21
Registration statement (foreign)
4:57pm
F-1
EX-10.10
skt0 259yhf
15 Jan 21
Registration statement (foreign)
4:57pm
DRS/A
EX-10.9
7hruapf907 wphxwd
22 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
yiqx 8mwaa5urzgs4u9
19 Nov 20
Draft registration statement (amended)
12:00am
DRS
m4q himlp64bx3t4
17 Nov 20
Draft registration statement
12:00am
- Prev
- 1
- Next